Madrigal Pharmaceuticals
Price & Volume
Stats
See more52W Range | $265-$615 |
Market Cap | $11.6B |
Shares Short | 3M |
Financials
See moreRevenue (12 Mos) | $740.6M |
Revenue Growth (YoY) | 362% |
Gross Profit (12 Mos) | $705.4M |
Diluted EPS | -$12.90 |
News
See moreYahoo Finance • 19 days ago
Here are the most and least likely M&A targets in biotech, according to Truist
Yahoo Finance • 24 days ago
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance • 29 days ago
2 Predictions for Novo Nordisk in 2026
Yahoo Finance • last month
This Biotech Fund Just Dumped $14.8 Million in MBX Biosciences — Right Before Key 2026 Milestones
About
CEO | Mr. William J. Sibold |
CFO | Ms. Mardi C. Dier |
Address | Four Tower Bridge, West Conshohocken, PA, United States, 19428 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 528 |
